Adding Molecular Breast Imaging to DBT Beneficial for Dense Breasts
THURSDAY, Sept. 25, 2025 -- For women with dense breasts, the addition of molecular breast imaging (MBI) as a supplement to digital breast tomosynthesis (DBT) increases overall and invasive cancer detection, according to a study published online Sept. 23 in Radiology.
Carrie B. Hruska, Ph.D., from Mayo Clinic in Rochester, Minnesota, and colleagues examined the performance of MBI as a supplement to DBT in 2,978 women with dense breasts in a prospective, multicenter trial. Participants underwent two annual screening rounds of DBT and MBI to assess the incremental cancer detection rate (CDR; cancers per 1,000 screenings) of supplemental MBI.
The researchers found that the CDR was 5.0 and 11.8 percent with DBT and DBT plus prevalence screening MBI, respectively (incremental CDR, 6.7 percent), at year 1; the corresponding invasive CDR was 3.0 and 7.7 percent, respectively (invasive incremental CDR, 4.7 percent). At year 2, the CDR was 5.8 and 9.3 percent with DBT and DBT plus incidence screening MBI, respectively (incremental CDR, 3.5 percent), and invasive CDR was 1.5 and 3.9 percent with DBT and DBT plus incidence screening MBI, respectively (invasive incremental CDR, 2.3 percent). The one-year recall rate was 8.6 and 17.9 percent with DBT and DBT plus prevalence screening MBI, respectively; at two years, the recall rates were 8.9 and 13.8 percent with DBT and DBT plus incidence screening MBI, respectively. Overall, 29 individuals had cancer detected only with MBI: 72 percent had invasive cancers, 90 percent had node-negative cancers, and 20 percent had advanced cancers.
"DBT doesn't find all cancers, and women need to understand its limitations and consider how supplemental screening can fill the gap," Hruska said in a statement.
Several authors disclosed ties to CMR Naviscan.
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Guidelines Developed for Postmastectomy Radiation Therapy
THURSDAY, Sept. 25, 2025 -- In a clinical practice guideline published online Sept. 16 in Practical Radiation Oncology, recommendations are presented for the use of postmastectomy...
Wrist Cooling May Help Manage Vasomotor Symptoms
WEDNESDAY, Sept. 24, 2025 -- Targeted wrist cooling may offer a safe approach for managing vasomotor symptoms, according to a study published online Sept. 20 in Endocrinology...
Radiation Exposure From Medical Imaging Linked to Hematologic Cancer Risk in Children
FRIDAY, Sept. 19, 2025 -- Exposure to radiation from medical imaging is associated with a small but significantly increased risk for hematologic cancer among children, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.